This announcement is a separate document:
四環醫藥：擬分拆軒竹生物於上海證券交易所獨立上市之最新進展
SIHUAN PHARM: UPDATE ON THE PROGRESS OF THE PROPOSED SPIN-OFF OF XUANZHU BIOPHARMACEUTICAL FOR INDEPENDENT LISTING ON THE SHANGHAI STOCK EXCHANGE
Sep 27, 2022 06:05
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.